Maze Therapeutics Up Over 21%, On Pace for Largest Percent Increase Since September 2025 -- Data Talk
Dow Jones2026/09/22 16:50Maze Therapeutics, Inc. (MAZE) is currently at $27.23, up $4.84 or 21.62%
--Would be highest close since Aug. 28, 2026, when it closed at $27.44
--On pace for largest percent increase since Sept. 11, 2025, when it rose 54.81%
--Snaps a five day losing streak
--Up 2.48% month-to-date
--Down 34.27% year-to-date
--Down 47.47% from its all-time closing high of $51.84 on March 12, 2026
--Up 9.45% from 52 weeks ago (Sept. 23, 2025), when it closed at $24.88
--Down 47.47% from its 52-week closing high of $51.84 on March 12, 2026
--Up 21.62% from its 52-week closing low of $22.39 on Sept. 21, 2026
--Traded as high as $29.40; highest intraday level since Aug. 26, 2026, when it hit $30.40
--Up 31.31% at today's intraday high; largest intraday percent increase since Sept. 11, 2025, when it rose as much as 59.18%
All data as of 12:44:05 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 22, 2026 12:50 ET (16:50 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Vivic delays annual report filing, expects Form 10-K within 15 days of due date

Prime Medicine's PM647 Clears Key Regulatory Hurdle, Oppenheimer Says